Similarly, a previous study of patients with colorectal cancer showed that Tregs suppressed effector CD4+ T cell responses to tumor-associated antigen before tumor resection, and the suppression was associated with tumor recurrence28. This evidence concerns the gene CD4 and neoplasm.